T1	Participants 442 600	Twenty-eight children (27 boys) ages 3 to 11 years (M = 5.8) with a primary diagnosis of autistic disorder received either placebo or lamotrigine twice daily.
T2	Participants 0 96	Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial.
